MGTA Annual SG&A
$25.76 M
-$2.17 M-7.75%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual selling, general & administrative expenses is $25.76 million, with the most recent change of -$2.17 million (-7.75%) on December 31, 2022. During the last 3 years, it has risen by +$2.00 million (+8.42%).MGTA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly SG&A
$5.32 M
-$814.00 K-13.27%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly selling, general & administrative expenses is $5.32 million, with the most recent change of -$814.00 thousand (-13.27%) on June 30, 2023. Over the past year, it has dropped by -$1.16 million (-17.93%).MGTA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA TTM SG&A
-$1.65 B
-$68.69 M-4.35%
30 June 2023
Summary:
As of January 21, 2025, MGTA TTM selling, general & administrative expenses is -$1.65 billion, with the most recent change of -$68.69 million (-4.35%) on June 30, 2023. Over the past year, it has dropped by -$1.68 billion (-5940.60%).MGTA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | -17.9% | -5940.6% |
| 3 y3 years | +8.4% | -28.1% | -6272.1% |
| 5 y5 years | +229.1% | +22.5% | -7042.3% |
MGTA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -8.3% | -28.6% | -5940.4% |
Magenta Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $5.32 M(-13.3%) | $23.44 M(-4.7%) |
| Mar 2023 | - | $6.13 M(+3.2%) | $24.61 M(-4.5%) |
| Dec 2022 | $25.76 M(-7.8%) | $5.94 M(-1.8%) | $25.76 M(-4.0%) |
| Sept 2022 | - | $6.05 M(-6.6%) | $26.84 M(-4.9%) |
| June 2022 | - | $6.48 M(-11.1%) | $28.24 M(-0.0%) |
| Mar 2022 | - | $7.29 M(+3.7%) | $28.24 M(+1.1%) |
| Dec 2021 | $27.93 M(-0.6%) | $7.03 M(-5.7%) | $27.93 M(+0.8%) |
| Sept 2021 | - | $7.45 M(+15.0%) | $27.71 M(+3.2%) |
| June 2021 | - | $6.48 M(-7.0%) | $26.85 M(-3.3%) |
| Mar 2021 | - | $6.97 M(+2.3%) | $27.77 M(-1.1%) |
| Dec 2020 | $28.09 M | $6.81 M(+3.2%) | $28.09 M(+3.3%) |
| Sept 2020 | - | $6.59 M(-10.9%) | $27.20 M(+1.8%) |
| June 2020 | - | $7.40 M(+1.7%) | $26.73 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $7.28 M(+22.9%) | $25.23 M(+6.2%) |
| Dec 2019 | $23.76 M(+27.6%) | $5.92 M(-3.2%) | $23.76 M(+1.6%) |
| Sept 2019 | - | $6.12 M(+3.6%) | $23.38 M(+3.7%) |
| June 2019 | - | $5.91 M(+1.6%) | $22.54 M(+7.5%) |
| Mar 2019 | - | $5.81 M(+4.9%) | $20.98 M(+12.7%) |
| Dec 2018 | $18.62 M(+137.9%) | $5.54 M(+4.8%) | $18.62 M(+18.6%) |
| Sept 2018 | - | $5.28 M(+21.7%) | $15.70 M(+28.5%) |
| June 2018 | - | $4.34 M(+25.6%) | $12.22 M(+24.8%) |
| Mar 2018 | - | $3.46 M(+32.0%) | $9.80 M(+25.1%) |
| Dec 2017 | $7.83 M(+124.6%) | $2.62 M(+45.1%) | $7.83 M(+50.3%) |
| Sept 2017 | - | $1.80 M(-5.7%) | $5.21 M(+53.0%) |
| June 2017 | - | $1.92 M(+28.6%) | $3.40 M(+128.6%) |
| Mar 2017 | - | $1.49 M | $1.49 M |
| Dec 2016 | $3.49 M | - | - |
FAQ
- What is Magenta Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Magenta Therapeutics?
- What is Magenta Therapeutics annual SG&A year-on-year change?
- What is Magenta Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly SG&A year-on-year change?
- What is Magenta Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Magenta Therapeutics?
- What is Magenta Therapeutics TTM SG&A year-on-year change?
What is Magenta Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of MGTA is $25.76 M
What is the all time high annual SG&A for Magenta Therapeutics?
Magenta Therapeutics all-time high annual selling, general & administrative expenses is $28.09 M
What is Magenta Therapeutics annual SG&A year-on-year change?
Over the past year, MGTA annual selling, general & administrative expenses has changed by -$2.17 M (-7.75%)
What is Magenta Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of MGTA is $5.32 M
What is the all time high quarterly SG&A for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly selling, general & administrative expenses is $7.45 M
What is Magenta Therapeutics quarterly SG&A year-on-year change?
Over the past year, MGTA quarterly selling, general & administrative expenses has changed by -$1.16 M (-17.93%)
What is Magenta Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of MGTA is -$1.65 B
What is the all time high TTM SG&A for Magenta Therapeutics?
Magenta Therapeutics all-time high TTM selling, general & administrative expenses is $28.24 M
What is Magenta Therapeutics TTM SG&A year-on-year change?
Over the past year, MGTA TTM selling, general & administrative expenses has changed by -$1.68 B (-5940.60%)